Logo
Nano Cannula 30g 25mm

Nano Cannula 30g 25mm

JBP

Medical device – sterile single-use blunt-tip cannula for injectable treatments
  • Manufacturer leaflet for JBP Nano Cannula displays a CE conformity mark (CE 1293) for the Nano Cannula range, indicating conformity with relevant European medical device requirements.
  • The same leaflet shows regulatory and quality marks including KFDA and KGMP, indicating compliance with South Korean medical device and manufacturing standards for this product line.
  • Device labelling includes SINGLE USE and STERILE EO symbols, consistent with international medical device labelling conventions for ethylene Oxide Sterilised disposable devices.
  • Some European distributors (e.g. NordicMSS) explicitly describe JBP Nano Cannula variants as CE Marked medical devices and list them under needles and cannulas categories for professional use.
  • Distributors such as AD Surgical describe the Ultra Thin Wall Nano Cannula as a "Prescription Only / Professional Use Device", reinforcing its status as a regulated medical device intended for use by licensed healthcare professionals.
  • LPG Clinics Wholesale states on its website that all products it supplies are CE or CPNP approved where appropriate, which encompasses this cannula as part of its needles & cannulas portfolio, although no specific CE certificate number for this size is listed.
Ultra-thin wall hypodermic cannula (30G \u00d7 25 mm) with separate punching needle for aesthetic injections

Description

Nano Cannula 30g 25mm is an ultra-thin wall, blunt-tip flexible cannula from the JBP Nano Cannula range, supplied by LPG Clinics Wholesale as a sterile, single-use medical device for professional injectable treatments. The cannula is designed to reduce damage to hypodermal tissues compared with conventional needles, providing smoother insertion with less resistance, minimising hematomas, swelling and post-treatment discomfort. The device incorporates a micro-polished side opening and wide inner diameter to allow higher-viscosity solutions to be injected through a smaller entry point, and is supplied with a matching sharp punching needle to create the initial skin entry prior to cannula insertion. It is marketed for use in aesthetic and dermatologic procedures such as local anaesthetics, mesotherapy, placenta injections and Botox or collagen injections.

Bnefits

  • Reduces damage to hypodermal tissues compared with conventional sharp needles, supporting gentler injection procedures.
  • Ultra-thin wall cannula with wide inner diameter allows smooth, low-pressure injection of higher-viscosity solutions through a smaller entry point.
  • Blunt-tip flexible cannula is designed to glide under the skin with less trauma, helping to minimise hematomas, bruising, swelling and post-procedure pain.
  • Micro-polished cutting edge at the cannula port is intended to lessen friction and tissue damage during advancement.
  • Directional marking on the hub indicates the orientation of the cannula opening for more precise placement of injectables.
  • Depth markings in centimetres on the cannula provide a visual guide to injection depth.
  • Each cannula kit includes a dedicated sharp punching needle to create the initial entry site, improving control and convenience for the practitioner.
  • Sterilised by ethylene oxide (EO) gas and supplied as single-use, supporting high standards of infection control in clinical practice.

Indications

  • Delivery of local anaesthetics via blunt-tip cannula in aesthetic and dermatologic procedures.
  • Mesotherapy injections using a cannula technique.
  • Placenta-derived injectable treatments administered with a cannula.
  • Botox (botulinum toxin) injections using a cannula technique where appropriate.
  • Collagen and other dermal filler injections using a cannula to reduce needle passes and tissue trauma.
  • General use in professional aesthetic medicine where a 30G × 25 mm blunt-tip cannula is clinically appropriate and permitted by local regulations.

Composition

  • Thin-walled cannula with a wide inner diameter and corresponding punching needle; detailed material composition (e.g. specific alloys or polymers) is not publicly listed in accessible product literature.
  • Sterile, single-use cannula and punching needle sterilised by ethylene oxide (EO) gas, as indicated in manufacturer and distributor materials.
  • For this size variant, the JBP Nano Cannula specification table lists a 30G cannula with outer diameter 0.30 mm and length 25 mm, supplied with a 27G × 13 mm punching needle.
  • Supplied as a medical device with labelling that includes CE mark, single-use symbol and sterile EO indication; further internal component details are not publicly listed.

Formulation

  • Device type: ultra-thin wall, blunt-tip flexible hypodermic cannula with separate sharp punching needle.
  • Size and dimensions for this variant: 30G cannula, outer diameter 0.30 mm, length 25 mm; associated punching needle 27G with 13 mm length, as per JBP Nano Cannula size specification.
  • Design features include a wide inner diameter relative to gauge, a micro-polished side opening (port) and a flexible shaft intended to allow smooth advancement under the skin.
  • Cannula hub incorporates a directional marking to indicate the orientation of the cannula opening during injection.
  • Cannula shaft bears depth markings in centimetres to assist practitioners in gauging insertion depth.
  • Sterilisation method: ethylene oxide (EO) gas; supplied sterile and marked as single-use disposable.
  • Marketed specifically as part of the JBP Nano Cannula range of ultra-thin wall cannulas for aesthetic and medical injection procedures.

Packaging

  • Pack configuration commonly described as a box containing 24 cannulas (24 pieces per pack), consistent with JBP Nano Cannula range documentation and multiple distributor listings.
  • Manufacturer leaflet for JBP Nano Cannula states "24 kits/box (each kit includes 1 punching nanoneedle)", indicating that each sterile kit contains one cannula and one associated punching needle.
  • Packaging is labelled as SINGLE USE and includes symbols for CE marking, EO gas sterilisation and other regulatory marks (e.g. KFDA, KGMP) on the Nano Cannula leaflet.
  • LPG Clinics Wholesale lists the product as "Nano Cannula 30g 25mm" within its Needles & Cannulas category, sold in box quantities for professional clinical use.
  • Outer carton artwork and language may vary by distributor and market; detailed box artwork for the LPG Clinics Wholesale presentation is not publicly listed.

Usage

  • Intended for professional use only; some distributor literature categorises the Nano Cannula as a prescription-only / professional-use medical device.
  • Supplied sterile and marked SINGLE USE; cannula and punching needle should be used once and then disposed of in an appropriate sharps container.
  • Inspect the sterile packaging before use and do not use if the package is damaged or opened (general requirement stated or implied in device literature and standard medical device practice).
  • Each kit provides a sharp punching needle that is used to make an initial skin entry point at the planned injection site, after which the blunt-tip cannula is introduced through the same opening to deliver the injectable product.
  • Depth markings on the cannula shaft and the directional hub marking are used by the practitioner to control insertion depth and to orient the cannula opening for precise placement of injectate.
  • The device is promoted for use with local anaesthetics, mesotherapy solutions, placenta-derived products, Botox and collagen or other dermal fillers; selection of specific products and techniques should follow clinical judgement, product SmPC/PIL (where applicable) and local regulations.
  • Clinicians should follow the official Instructions for Use (IFU) supplied with the product and adhere to standard aseptic technique, infection-control procedures and clinical guidelines; detailed step-by-step IFU beyond the high-level points above are not publicly listed.

Contraindications

  • Not publicly listed for this specific cannula size; users should refer to the official Instructions for Use (IFU) supplied with the device and comply with local regulations and clinical guidelines when assessing patient suitability for cannula-based injections.

Adverse Effects

  • Specific adverse-effect profiles are not publicly listed for this cannula in accessible manufacturer or regulator documents.
  • Marketing and technical literature emphasises that the ultra-thin wall, blunt tip, flexible design and wide inner diameter aim to reduce common needle-related issues such as internal bleeding, hematomas, swelling and post-injection pain compared with conventional sharp needles; however, no quantified adverse-event rates are provided.
  • Practitioners must rely on general risks associated with cannula-based injections and on the safety information of the injected medicinal or cosmetic products, in addition to any information contained in the device IFU.

Storage Conditions

  • Not publicly listed in detail for this specific product.
  • As indicated by the sterile, single-use labelling, the device is supplied in sealed sterile packaging; storage should follow the instructions on the outer carton and pouch provided with the product.

Duration

Not applicable \u2013 this is a single-use injection device employed during a procedure; no defined treatment course or duration is specified in publicly available product literature.

Onset

Not applicable \u2013 as a cannula, the device itself has no pharmacological onset of effect; clinical onset depends on the medicinal or cosmetic product being injected, which is not specified in the device documentation.

Browse more Medical device \u2013 sterile single-use blunt-tip cannula for injectable treatments

Top Treatments

Top Cities in the UK